Pharma Surge
Pharma Surge
Intelligence Layer
🇬🇧·Jun 1Research

Fuzuloparib enhances radiosensitivity of gain-of-function mutant p53 R273H NSCLC by promoting SLC7A11/GSH/GPX4 axis mediated ferroptosis

Publisher

n
npj Precision Oncology

UK

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

At a glance

Publisher
npj Precision Oncology
Region
UK
Scope
Research
Published
June 1, 2026

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on nature.com

Leave the platform to read the original full article on the publisher site.

Source: npj Precision Oncology

Scope: Research

Open original article
Fuzuloparib enhances radiosensitivity of gain-of-function mutant p53 R273H NSCLC by promoting SLC7A11/GSH/GPX4 axis mediated ferroptosis | Pharma Surge